Evidence map›Paper›PMID 26399233›Full record

ArticleBMC health services research2015

A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.

Lorenzo Zammarchi, Gianluigi Casadei, Marianne Strohmeyer, Filippo Bartalesi, Carola Liendo, Alberto Matteelli, Maurizio Bonati, Eduardo Gotuzzo, Alessandro Bartoloni, COHEMI project study group

Open access · goldAbstract readScoping Review
In one paragraph

Article in BMC health services research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Guideline
  2. Prevalence rates of six selected infectious diseases among African migrants and refugees: a systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region.The European journal of health economics : HEPAC : health economics in prevention and care · 2021
    Article
  10. Review
  11. Infectious Diseases among Refugee Children.Children (Basel, Switzerland) · 2019
    Review
  12. Building a European database to gather multi-country evidence on active and latent TB screening for migrants.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Screening for neurocysticercosis in internationally adopted children: yield, cost and performance of serological tests, Italy, 2001 to 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Article
  17. Defining a migrant-inclusive tuberculosis research agenda to end TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Review
  18. Extended screening for infectious diseases among newly-arrived asylum seekers from Africa and Asia, Verona province, Italy, April 2014 to June 2015.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Observational
  19. Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Article
  20. Demographic predictors of active tuberculosis in people migrating to British Columbia, Canada: a retrospective cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Lorenzo ZammarchiInfectious Diseases Unit, Department of Experimental & Clinical Medicine, University of Florence School of Medicine, Largo Brambilla 3, 50134, Florence, Italy. lorenzo.zammarchi@unifi.it.
Gianluigi CasadeiLaboratory for Mother and Child Health, Department of Public Health, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Via G. La Masa 19, 20156, Milan, Italy. gianluigi.casadei@guest.marionegri.it.
Marianne StrohmeyerInfectious Diseases Unit, Department of Experimental & Clinical Medicine, University of Florence School of Medicine, Largo Brambilla 3, 50134, Florence, Italy. strohmeyerm@aou-careggi.toscana.it.
Filippo BartalesiSOD Malattie Infettive e Tropicali, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy. bartalesif@aou-careggi.toscana.it.
Carola LiendoInstituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Barrios Altos, Lima, Peru. carola.liendo@upch.pe.
Alberto MatteelliInstitute of Infectious and Tropical Diaseases, WHO Collaborting Centre for TB Co-infection and TB Elimination, University of Brescia, Brescia, Italy. matteelli@med.unibs.it.
Maurizio BonatiLaboratory for Mother and Child Health, Department of Public Health, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Via G. La Masa 19, 20156, Milan, Italy. mother_child@marionegri.it.
Eduardo GotuzzoInstituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Barrios Altos, Lima, Peru. eduardo.gotuzzo@upch.pe.
Alessandro BartoloniInfectious Diseases Unit, Department of Experimental & Clinical Medicine, University of Florence School of Medicine, Largo Brambilla 3, 50134, Florence, Italy. alessandro.bartoloni@unifi.it.
COHEMI project study group
Mario Negri Institute for Pharmacological Research · ITUniversidad Peruana Cayetano Heredia · PEAzienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn low-incidence countries, most tuberculosis (TB) cases occur among migrants and are caused by reactivation of latent tuberculosis infection (LTBI) acquired in the country of origin. Diagnosis and treatment of LTBI are rarely implemented to reduce the burden of TB in immigrants, partly because the cost-effectiveness profile of this intervention is uncertain. The objective of this research is to perform a review of the literature to assess the cost-effectiveness of LTBI diagnosis and treatment strategies in migrants.

methodsScoping review of economic evaluations on LTBI screening strategies for migrants was carried out in Medline.

resultsNine studies met the inclusion criteria. LTBI screening was cost-effective according to seven studies. Findings of four studies support interferon gamma release assay as the most cost-effective test for LTBI screening in migrants. Two studies found that LTBI screening is cost-effective only if carried out in immigrants who are contacts of active TB cases. DISCUSSION AND

conclusionsOur findings support the cost-effectiveness of LTBI diagnostic and treatment strategies in migrants especially if they are focused on young subjects from high incidence countries. These strategies could represent and adjunctive and synergistic tool to achieve the ambitious aim of TB elimination.

Indexed as

Transients and MigrantsCommunicable DiseasesCost-Benefit AnalysisDental CareFemaleHumansIncidenceInterferon-gamma Release TestsLatent TuberculosisMaleMass ScreeningTuberculin TestTuberculosis

Identifiers

PMID26399233
PMCPMC4581517
OpenAlexW1947117160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.